- ineffective management of land-based pollution sources that can impact shellfish growing areas,
- inadequate sanitary controls to prevent the discharge of human fecal waste from fish farms and commercial fishing and aquaculture vessels operating in and adjacent to shellfish growing areas,
- detection of norovirus in shellfish growing areas analyzed by FDA during the evaluation.
The removal of Korean shellfish shippers from the ICSSL is intended to stop the import of molluscan shellfish harvested from polluted waters. Korean molluscan shellfish that entered the United States prior to May 1 and any product made with Korean molluscan shellfish are considered adulterated under the Federal Food, Drug, and Cosmetic Act.
FDA recommends that food distributors, retailers, and food service operators remove from sale or service, all fresh, frozen, and processed Korean molluscan shellfish and any product subsequently made with them. Korean molluscan shellfish represents only a small fraction of the oysters, clams, mussels, and scallops sold in the United States. FDA is currently working to determine the distribution of the product.
Distributors, retailers, and food service operators can continue to receive molluscan shellfish from any of the other shellfish shippers listed in the ICSSL.
Consumers who have recently bought molluscan shellfish and are concerned that it may have come from Korea, should contact the store from which it was purchased and ask where the shellfish were harvested. Product from Korea should not be consumed.
(This Constituent Update can be found at http://www.fda.gov/Food/NewsEvents/ConstituentUpdates/ucm304600.htm)